Vanguard Group
ONCT

Vanguard Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-139,884
Closed -$185K 4385
2024
Q3
$185K Sell
139,884
-3,159
-2% -$4.17K ﹤0.01% 4150
2024
Q2
$1.09M Hold
143,043
﹤0.01% 3764
2024
Q1
$1.29M Sell
143,043
-2,717,863
-95% -$24.5M ﹤0.01% 3729
2023
Q4
$1.53M Hold
2,860,906
﹤0.01% 3693
2023
Q3
$858K Hold
2,860,906
﹤0.01% 3890
2023
Q2
$987K Sell
2,860,906
-3,234
-0.1% -$1.12K ﹤0.01% 3900
2023
Q1
$2.25M Hold
2,864,140
﹤0.01% 3630
2022
Q4
$2.86M Buy
2,864,140
+923
+0% +$923 ﹤0.01% 3532
2022
Q3
$2.55M Buy
2,863,217
+728,200
+34% +$649K ﹤0.01% 3647
2022
Q2
$2.37M Sell
2,135,017
-190,498
-8% -$211K ﹤0.01% 3736
2022
Q1
$3.23M Buy
2,325,515
+192,189
+9% +$267K ﹤0.01% 3739
2021
Q4
$4.84M Buy
2,133,326
+12,703
+0.6% +$28.8K ﹤0.01% 3627
2021
Q3
$8.84M Buy
2,120,623
+13,023
+0.6% +$54.3K ﹤0.01% 3315
2021
Q2
$10M Buy
2,107,600
+345,584
+20% +$1.64M ﹤0.01% 3198
2021
Q1
$14.7M Buy
1,762,016
+80,512
+5% +$670K ﹤0.01% 2944
2020
Q4
$8.24M Buy
1,681,504
+1,403,198
+504% +$6.88M ﹤0.01% 3093
2020
Q3
$473K Sell
278,306
-6,198
-2% -$10.5K ﹤0.01% 3830
2020
Q2
$808K Sell
284,504
-345
-0.1% -$980 ﹤0.01% 3659
2020
Q1
$834K Hold
284,849
﹤0.01% 3543
2019
Q4
$1.13M Buy
284,849
+164,773
+137% +$651K ﹤0.01% 3611
2019
Q3
$601K Buy
120,076
+88,294
+278% +$442K ﹤0.01% 3775
2019
Q2
$211K Sell
31,782
-157,279
-83% -$1.04M ﹤0.01% 3969
2019
Q1
$227K Sell
189,061
-8,548
-4% -$10.3K ﹤0.01% 3900
2018
Q4
$154K Sell
197,609
-269,854
-58% -$210K ﹤0.01% 3937
2018
Q3
$734K Buy
467,463
+75,539
+19% +$119K ﹤0.01% 3785
2018
Q2
$6M Buy
391,924
+114,533
+41% +$1.75M ﹤0.01% 3143
2018
Q1
$4.92M Sell
277,391
-1,562
-0.6% -$27.7K ﹤0.01% 3161
2017
Q4
$3.55M Buy
278,953
+131,121
+89% +$1.67M ﹤0.01% 3256
2017
Q3
$1.22M Buy
147,832
+71,353
+93% +$586K ﹤0.01% 3540
2017
Q2
$404K Sell
76,479
-6,346
-8% -$33.5K ﹤0.01% 3760
2017
Q1
$402K Hold
82,825
﹤0.01% 3788
2016
Q4
$437K Sell
82,825
-810,521
-91% -$4.28M ﹤0.01% 3757
2016
Q3
$700K Sell
893,346
-7,247
-0.8% -$5.68K ﹤0.01% 3673
2016
Q2
$495K Hold
900,593
﹤0.01% 3798
2016
Q1
$451K Buy
900,593
+4,300
+0.5% +$2.15K ﹤0.01% 3811
2015
Q4
$628K Buy
896,293
+100
+0% +$70 ﹤0.01% 3767
2015
Q3
$681K Buy
896,193
+93,667
+12% +$71.2K ﹤0.01% 3752
2015
Q2
$1.18M Buy
802,526
+12,460
+2% +$18.3K ﹤0.01% 3617
2015
Q1
$533K Buy
790,066
+11,536
+1% +$7.78K ﹤0.01% 3813
2014
Q4
$569K Buy
778,530
+13,200
+2% +$9.65K ﹤0.01% 3687
2014
Q3
$565K Buy
765,330
+55,917
+8% +$41.3K ﹤0.01% 3682
2014
Q2
$979K Sell
709,413
-26,372
-4% -$36.4K ﹤0.01% 3491
2014
Q1
$1.13M Buy
735,785
+117,990
+19% +$180K ﹤0.01% 3416
2013
Q4
$1.02M Sell
617,795
-305,814
-33% -$505K ﹤0.01% 3410
2013
Q3
$1.86M Sell
923,609
-858
-0.1% -$1.73K ﹤0.01% 3163
2013
Q2
$6.1M Buy
+924,467
New +$6.1M ﹤0.01% 2552